Liu Yao, Swearingen Rebecca
Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, 2870 University Ave, Ste 206, Madison, WI, 53705, USA.
Curr Diab Rep. 2017 Aug 31;17(10):94. doi: 10.1007/s11892-017-0911-2.
Diabetic retinopathy remains the leading cause of blindness among working-age US adults even though timely screening and treatment prevent 90% of blindness. We summarize current knowledge and perspectives to better understand why diabetic eye screening rates remain low and future directions towards preventing blindness from diabetes.
Significant advancements in the past 10 years include primary care and patient-oriented interventions as well as the use of teleophthalmology. In England, diabetic eye disease is no longer the leading cause of certifiable blindness following the implementation of a national teleophthalmology program for diabetic retinopathy. Multiple workflow and systems-level barriers affect providers. Patient barriers include a limited understanding of screening and lack of access to care. Interventions have been developed, but new barriers exist towards sustaining their impact. More research is needed to identify and implement the best practices to increase diabetic eye screening rates long-term.
尽管及时筛查和治疗可预防90%的失明,但糖尿病视网膜病变仍是美国工作年龄成年人失明的主要原因。我们总结当前的知识和观点,以更好地理解糖尿病眼部筛查率为何仍然较低,以及预防糖尿病致盲的未来方向。
过去10年取得的重大进展包括初级保健和以患者为导向的干预措施以及远程眼科的应用。在英国,实施全国糖尿病视网膜病变远程眼科项目后,糖尿病眼病不再是可认证失明的主要原因。多种工作流程和系统层面的障碍影响着医疗服务提供者。患者方面的障碍包括对筛查的了解有限以及难以获得医疗服务。虽然已经开发了一些干预措施,但在维持其效果方面存在新的障碍。需要更多研究来确定并实施最佳实践,以长期提高糖尿病眼部筛查率。